Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc, 71022 [2023-22623]

Download as PDF 71022 Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices Controlled substance Drug code Fentanyl ........................................................................................................................................................................... The company plans to bulk manufacture the listed controlled substances in bulk for distribution and sale to its customers. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as a synthetic. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the manufacturing of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Claude Redd, Acting Deputy Assistant Administrator. [FR Doc. 2023–22627 Filed 10–12–23; 8:45 am] BILLING CODE P [FR Doc. 2023–22623 Filed 10–12–23; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–1271] Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Cambridge Isotope Laboratories, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 12, 2023. Such persons may also file a written request for a hearing on the application on or before December 12, 2023. SUMMARY: Drug code lotter on DSK11XQN23PROD with NOTICES1 [Docket No. DEA–1273] Bulk Manufacturer of Controlled Substances Application: Curia New York, Inc Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Curia New York, Inc has applied to be registered as a bulk SUMMARY: VerDate Sep<11>2014 16:55 Oct 12, 2023 Jkt 262001 manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 12, 2023. Such persons may also file a written request for a hearing on the application on or before December 12, 2023. DATES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not ADDRESSES: PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 II The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on August 25, 2023, Cambridge Isotope Laboratories, Inc 50 Frontage Road, Andover, Massachusetts 01810–5413, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Tetrahydrocannabinols ............................................................................................................................................ Claude Redd, Acting Deputy Assistant Administrator. 9801 ADDRESSES: DEPARTMENT OF JUSTICE Controlled substance The company plans to synthetically bulk manufacture the controlled substance Tetrahydrocannabinols to produce analytical standards for distribution to its customers. No other activities for this drug code is authorized for this registration. Schedule 7370 Schedule I instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on August 10, 2023, Curia New York, Inc, 33 Riverside Avenue, Rensselaer, New York 12144–2951, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance Drug code Schedule Marihuana ................................... Tetrahydrocannabinols ............... Amphetamine .............................. Lisdexamfetamine ....................... Methylphenidate .......................... Pentobarbital ............................... Codeine ....................................... Dihydrocodeine ........................... Oxycodone .................................. Hydromorphone .......................... Hydrocodone ............................... Meperidine .................................. Morphine ..................................... 7360 7370 1100 1205 1724 2270 8333 9050 9143 9150 9193 9230 9300 I I II II II II II II II II II II II E:\FR\FM\13OCN1.SGM 13OCN1

Agencies

[Federal Register Volume 88, Number 197 (Friday, October 13, 2023)]
[Notices]
[Page 71022]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22623]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1271]


Bulk Manufacturer of Controlled Substances Application: Cambridge 
Isotope Laboratories, Inc

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cambridge Isotope Laboratories, Inc has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
December 12, 2023. Such persons may also file a written request for a 
hearing on the application on or before December 12, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 25, 2023, Cambridge Isotope Laboratories, Inc 
50 Frontage Road, Andover, Massachusetts 01810-5413, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
      Controlled substance           Drug code           Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols...........            7370  I
------------------------------------------------------------------------

    The company plans to synthetically bulk manufacture the controlled 
substance Tetrahydrocannabinols to produce analytical standards for 
distribution to its customers. No other activities for this drug code 
is authorized for this registration.

Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-22623 Filed 10-12-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.